Allergen immunotherapy (AIT)-induced anaphylaxis is rare and more likely to result from subcutaneous vs sublingual immunotherapy (SCIT vs SLIT).

Patients with hereditary angioedema who switched from other drugs to donidalorsen for long-term prophylaxis experienced fewer attacks and improved disease control, according to a poster presented here ...